Send feedback

SMARCA2 p.Val850=

c.2550G>T · rs367639859 · VCV2998221

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00873%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3GERP 0.77, phastCons 1
Overall
CADD8.272PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00873% European (non-Finnish) · 103/1,179,968 alleles
Filtering AF 0.00733% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00684%
Overall 0.00651% 105/1,613,910 alleles · very rare exomes 102/1,461,782 · genomes 3/152,128 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.00873% 11,456
African / African-American 0.00267% 37,447

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SMARCA2
Protein
p.Val850=
Coding
c.2550G>T
MANE Select
NM_003070
dbSNP
rs367639859
Type
single nucleotide variant
Location
chr9:2086852 (GRCh38)
Gene constraint
LOEUF 0.317 · pLI 1.00 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 66.06 · 32 PDB
Residue 850
a β-strand; the helicase atp-binding domain
Full SMARCA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/smarca2-p-val850 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown